Steve Swann
About Steve Swann
Steve Swann is the Chief Scientific Officer with over 20 years of experience in computational technology marketing, having held leadership roles at Schrödinger, Iktos, and ProCeryon Biosciences.
Steve Swann's Current Role: Chief Scientific Officer
Steve Swann is the Chief Scientific Officer, leveraging his extensive experience in marketing strategies for computational technologies. In this role, he focuses on driving scientific innovation and integrating advanced computational methodologies into strategic business decisions. His leadership aims to enhance the efficacy of marketing initiatives through scientific advancements.
Steve Swann's Education and Academic Background
Steve Swann has a solid academic foundation in the sciences. He received a B.S. degree (Laurea) Magna Cum Laude in Physics from the University of Pavia, located in Italy. Furthering his education, he earned a Ph.D. in Theoretical Physics from the prestigious Rockefeller University. This academic background underpins his expertise in computational technologies and strategic business development.
Steve Swann's Experience at Schrödinger and Iktos
Steve Swann has held significant roles at both Schrödinger and Iktos. At Schrödinger, he served as Vice President, Strategic Business, where he contributed to the company's vision in computational chemistry. More recently, at Iktos, Swann undertook the roles of Senior Vice President and Head of US Operations, focusing on expanding the company's market presence and operational strategies within the United States.
Steve Swann's Role as Strategic Business Advisor to Nanome
In his capacity as a Strategic Business Advisor to Nanome, Steve Swann provided invaluable insights and guidance aimed at steering the company’s business strategies. His expertise in computational technologies and business development played a crucial role in advising Nanome on navigating the competitive landscape of their industry.
Steve Swann: Co-founder, President, and CEO of ProCeryon Biosciences
Steve Swann co-founded ProCeryon Biosciences and served as its President and CEO. In this leadership role, he was responsible for setting the strategic direction of the company, overseeing operations, and fostering innovation. His entrepreneurial venture into ProCeryon Biosciences underscores his commitment to advancing the frontiers of computational and biosciences technology.